Dyadic International (DYAI) Revenue (2018 - 2026)
Dyadic International's (DYAI) quarterly Revenue came in at $1.1 million in Q1 2026, up 182.28% year-over-year from $393572.0 in Q1 2025, and up 96.45% quarter-over-quarter from $565526.0 in Q4 2025.
Powered by 
Analysis
Dyadic International (DYAI) Revenue (2018 - 2026) Analysis & Trends
Dyadic International has disclosed Revenue across 9 years of filings, most recently posting $1.1 million for Q1 2026.
- In Q1 2026, Revenue rose 182.28% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $3.8 million (up 7.13% YoY), while the FY2025 annual figure was $3.1 million, down 11.59% from the prior year.
- Revenue came in at $1.1 million for Q1 2026 at Dyadic International, up from $565526.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $2.0 million in Q3 2024 to a low of $334617.0 in Q1 2024.
- Average Revenue over 5 years is $795635.2, with a median of $743726.0 recorded in 2022.
- Year-over-year, Revenue plunged 99.86% in 2022 and soared 393.0% in 2024.
- Over 5 years, Revenue stood at $743726.0 in 2022, then declined by 7.69% to $686535.0 in 2023, then increased by 19.06% to $817376.0 in 2024, then slumped by 30.81% to $565526.0 in 2025, then jumped by 96.45% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $1.1 million in Q1 2026, $565526.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.95 Bn | 195.96 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 180.35 Bn | 177.17 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 82.62 Bn | 74.62 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 61.19 Bn | 56.00 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.75 Bn | 30.44 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.58 Bn | 30.30 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.42 Bn | 29.42 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Dyadic International | 18.38 Mn | 10.42 Mn | - | 1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | 565,526.00 |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 966,630.00 |
| Mar 31, 2025 | 393,572.00 |
| Dec 31, 2024 | 817,376.00 |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 385,896.00 |
| Mar 31, 2024 | 334,617.00 |
| Dec 31, 2023 | 686,535.00 |
| Sep 30, 2023 | 397,060.00 |
| Jun 30, 2023 | 837,159.00 |
| Mar 31, 2023 | 978,052.00 |
| Dec 31, 2022 | 743,726.00 |
| Sep 30, 2022 | 879,597.00 |
| Jun 30, 2022 | 658,553.00 |
| Mar 31, 2022 | 648,427.00 |
| Dec 31, 2021 | 313,290.00 |
| Sep 30, 2021 | 692,929.00 |
| Jun 30, 2021 | 937,092.00 |